NES Implant

Product Overview

Alternative Name: Nestorone (NES) Single Rod Implant

Development Status: Inactive

Target: Female

Mode: Hormonal

Delivery Type: Subdermal

Duration Type: Long-acting

Description: A single rod, 2-year silastic subdermal implant containing 93 mg of Nestorone.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Late Development

Project Stage: Phase II

Status Details:
  • Phase IIb study stopped due to higher than expected failure rate in women who were not breastfeeding; Phase II in breastfeeding women successful both in efficacy to prevent pregnancy and safety in mothers and infants.

Download Product Report